Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors.

Radiographics : a review publication of the Radiological Society of North America, Inc - 1 Jan 2000

Kurokawa Ryo, Kurokawa Mariko, Baba Akira, Ota Yoshiaki, Pinarbasi Emile, Camelo-Piragua Sandra, Capizzano Aristides A, Liao Eric, Srinivasan Ashok, Moritani Toshio

Abstract excerpt

The World Health Organization (WHO) published the fifth edition of the WHO Classification of Tumors of the Central Nervous System (WHO CNS5) in 2021, as an update of the WHO central nervous system (CNS) classification system published in 2016. WHO CNS5 was drafted on the basis of recommendations from the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy (cIMPACT-NOW) and expounds the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Central Nervous System Neoplasms

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to World Health Organization

Source

Identifiers

PMID: 35802502
DOI: 10.1148/rg.210236

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors.PMID 35802502Read ↗

World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.Semantic proximity Read ↗

Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.Semantic proximity Read ↗

The 2021 WHO classification of central nervous system tumors: what neurologists need to know.Semantic proximity Read ↗

Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?Semantic proximity Read ↗

NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.Semantic proximity Read ↗

The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of RevisionSemantic proximity Read ↗

The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas.Semantic proximity Read ↗

[World Health Organization Classification of Central Nervous System Tumours, 5th Edition:Points of the Update and the Current Status].Semantic proximity Read ↗

[Evolution of Glioma Diagnosis: The WHO 2021 Classification and Beyond].Semantic proximity Read ↗

WHO CNS5 2021 includes specific mutations in gliomas that can be identified with MRI quantitative biomarkers.Semantic proximity Read ↗

2016 World Health Organization Classification of Central Nervous System Tumors.Semantic proximity Read ↗

Clinical features, MRI, molecular alternations, and prognosis of astrocytoma based on WHO 2021 classification of central nervous system tumors: A single-center retrospective study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.